EIS Eczacibasi Ilaç Sinai ve Finansal Yatirimlar Sanayi ve Ticaret Valuation

Q: What is the Fair Price of ECILC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ECILC (TRY46.02) is trading above our estimate of [[fair value]] (TRY6.22)

Is ECILC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ECILC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ECILC (TRY46.02) is trading above our estimate of fair value (TRY6.22)

Significantly Below Fair Value: ECILC is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ECILC?

Key metric: As ECILC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ECILC. This is calculated by dividing ECILC's market cap by their current earnings.
What is ECILC's PE Ratio?
PE Ratio	11x
Earnings	₺2.87b
Market Cap	₺31.54b

ECILC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.4x
Enterprise Value/EBITDA	100.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does ECILC's PE Ratio compare to its peers?

The above table shows the PE ratio for ECILC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	28.3x
LILAK Lila Kagit Sanayi Ve Ticaret	14.6x	n/a	₺15.7b
300791 Sirio Pharma	17.9x	21.1%	CN¥6.0b
HUMBLE Humble Group	67.3x	65.1%	SEK 4.8b
A018290 VT	13.5x	n/a	₩1.0t
ECILC EIS Eczacibasi Ilaç Sinai ve Finansal Yatirimlar Sanayi ve Ticaret	11x	n/a	₺31.5b

Price-To-Earnings vs Peers: ECILC is good value based on its Price-To-Earnings Ratio (11x) compared to the peer average (28.3x).

Price to Earnings Ratio vs Industry

How does ECILC's PE Ratio compare vs other companies in the Asian Personal Products Industry?

5 Companies	Price / Earnings	Estimated Growth	Market Cap

5 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: ECILC is good value based on its Price-To-Earnings Ratio (11x) compared to the Asian Personal Products industry average (24.9x).

Price to Earnings Ratio vs Fair Ratio

What is ECILC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ECILC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	11x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ECILC's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.